Delivery Order SPE2DR25D3501-SPE2DR26FM2GR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,400.36 to AmerisourceBergen Drug Corp for Albuterol HFA 90 mcg inhalers (8.5 grams) on August 25, 2025, with completion scheduled for August 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,177.63 to AmerisourceBergen Drug Corp for Albuterol HFA 90 mcg inhaler 8.5 gm, with an ultimate completion date of September 11, 2025. This competitive award uses firm fixed pricing with no set-aside designation and is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader supply relationship with the federal government for...
- The Defense Logistics Agency awarded a delivery order valued at $2,063.72 to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 mcg inhaler in 8.5 gram units. This competitively awarded, firm fixed-price delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's Corporate Office is headquartered. As a non-set-aside contract, this award was made through open...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,773.92 to AmerisourceBergen Drug Corp for Albuterol HFA 90 micrograms inhalers (8.5 grams) on July 17, 2025, with an ultimate completion date of July 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Albuterol HFA 90 MCG Inhaler in 8.5GM units, valued at $1,518.96. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $1,172.60 to Amerisourcebergen Drug Corp on January 8, 2026, for the supply of Albuterol HFA 90 micrograms inhalers (8.5 grams). This firm fixed-price delivery order is scheduled for completion by January 9, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, leveraging the contractor's existing indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,311.72 to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 mcg inhaler in 6.7 gram units. This firm fixed-price delivery order was competitively awarded without set-aside designation on January 7, 2026, with an ultimate completion date of January 8, 2026. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,001.00 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Albuterol HFA 90 mcg inhalers (8.5 grams). The contract is a firm fixed price delivery order with an ultimate completion date of September 2, 2025, and represents a non-competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,210.56 to AmerisourceBergen Drug Corp for Albuterol HFA 90 MCG inhalers (8.5GM) on January 5, 2026, with completion scheduled for January 6, 2026. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,393.92 to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 mcg inhaler in 8.5-gram units. This contract, awarded on January 9, 2026, is a firm fixed-price delivery order with an ultimate completion date of January 12, 2026 and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award utilized no set-aside provisions, indicating the contract was competitively...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM2GRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,166.52 to AmerisourceBergen Drug Corp for Albuterol HFA 90 MCG inhaler (8.5 grams) on January 13, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 31, 2031. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The delivery order for albuterol inhalers supports the Defense Health Agency and other federal healthcare systems' respiratory medication requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/12/26 |